INTRODUCTION
Spinal cord injury is severe trauma of the central nervous system. Over the years, various methods have been used to treat spinal cord injury, including surgical anastomosis, surgical decompression, omental transplantation, drug treatment, partial freeze, physical rehabilitation, and the application of enzyme preparations to reduce or eliminate connective tissue scarring. Although these methods can alleviate the pathological changes associated with spinal cord injury, they have been unable to provide satisfactory clinical improvement [1] [2] . Recently, cell transplantation has become a hot therapeutic approach for the treatment of spinal cord injury.
Neural stem cells are pluripotent stem cells that have the potential to self-replicate and undergo multi-directional differentiation. Neural stem cells not only promote neuroregeneration, but can also be used in gene therapy for nervous system diseases by undergoing genetic modification to express exogenous neurotransmitters, neurotrophic factors and metabolic enzymes. These cells help demyelinated nerve fibers and newborn nerve fibers undergo myelination to maintain their integrity [3] [4] .
Schwann cells are glial cells in the peripheral nervous system. After spinal cord injury, Schwann cells can migrate to the site of injury. These cells can secrete a variety of neurotrophic factors to promote neuronal survival and encourage neurite outgrowth and functional synapse formation. Furthermore, Schwann cells can produce extracellular matrix components and cell adhesion molecules. These molecules promote neurite outgrowth and serve as a scaffold for migrating neurons. They can also fill necrotic voids and inhibit glial scar formation to improve the microenvironment [5] [6] .
Olfactory ensheathing cells are the only glial cells present in both the peripheral and central nervous system. They exhibit characteristics of both astrocytes and Schwann cells. Olfactory ensheathing cells can express many molecules related to cell adhesion and neurite outgrowth, and they secrete a multitude of neurotrophic factors to provide a good environment for nerve regeneration. Olfactory ensheathing cells can pass through the glial scar to provide the appropriate conditions for axonal regeneration [7] [8] .
In this study, we analyzed research trends among cell transplantation studies using these three different cell types for spinal cord injury based on a bibliometric analysis of publications indexed in the Web of Science and published from 2002 to 2011. 
DATA SOURCES AND METHODOLOGY

Inclusion criteria
Inclusion criteria were as follows: (1) published peer-reviewed articles on any of the three types of cells, including original research articles, reviews, meeting abstracts, proceedings papers, book chapters, editorial material and news items, indexed in the Web of Science; (2) year of publication 2002-2011; and (3) citation database was Science Citation Index Expanded.
Exclusion criteria
We excluded articles that required manual searching or telephone access, documents that were not published in the public domain, and several corrected papers.
Outcomes for all articles referring to the three kinds of cells for the repair of spinal cord injury were assessed using the following criteria: (1) Table 1) .
Distribution of output by institution for publications on the use of neural stem cells to repair spinal cord injury indexed in the Web of Science and published from 2002 to 2011
A total of 537 articles were analyzed according to institution. Keio University in Japan and Harvard University in the USA were the most prolific research institutes ( Table 2) . Four of the top 10 research institutes publishing in this field were in the USA, two were in Canada, and one institute each was in Japan, Sweden, China and Korea. [9] , was cited 418 times, which was more times than any other papers (Table 3 ). Of the 10 most-cited papers, two were published in (Table 4) Experimental Neurology published 47 papers, followed Table 4) .
Distribution of output by institution for publications on the use of Schwann cells to repair spinal cord injury indexed in the Web of Science and published from 2002 to 2011
A total of 541 articles were analyzed by institution. University of California system and University of Miami in the USA were the most prolific research institutes ( Table  5 ). Five of the top 10 research institutes publishing in this field were in the USA, three were in Canada, and one institute each was in Germany and China. [19] , was cited 323 times, which was more than any other paper. Of the 10 most-cited papers, four were published in Journal of Neuroscience, and the remaining six papers were published in six different journals. Schwann cell but not olfactory ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused adult rat thoracic spinal cord [20] Takami T, Oudega M, Bates ML, et al.
Highly cited papers on the use of Schwann cells to repair spinal cord injury indexed in the Web
Journal of Neuroscience
Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome [13] Hofstetter CP, Holmström NA, Lilja JA, et al.
Nature Neuroscience
Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord [21] Fouad K, Schnell L, Bunge MB, et al.
Journal of Neuroscience
Guidance of glial cell migration and axonal growth on electrospun nanofibers of poly-epsilon-caprolactone and a collagen/poly-epsilon-caprolactone blend [22] Schnell E, Klinkhammer K, Balzer S, et al. Table 7) .
Distribution of output by institution for publications on the use of olfactory ensheathing cells to repair spinal cord injury indexed in the Web of Science and published from 2002 to 2011
A total of 351 articles were analyzed by institution. University of British Columbia in Canada and Yale University in the USA were the most prolific research institutes (Table 8) .
Three of the top 11 research institutes publishing in this field were in the UK, two each were in the USA and Canada, and one institute each was in Germany, Australia, China and France. [9] , was cited 418 times, which was more than any other paper. Of the 10 most-cited papers, two were published in Brain, and the remaining eight papers were published in eight different journals. [34] . We believe that with further investigation, researchers will make substantial breakthroughs in the treatment of spinal cord injury. [9] Teng YD, Lavik EB, Qu X, et al.
